Cardio Buzz

Smart Wearables & heart beats Part 3: AFib and VTac

How can wearables and smartwatches guide the diagnosis and management of serious arrhythmias like atrial fibrillation and ventricular tachycardia?

Smart Wearables & Heartbeats Part 2: Athletes

Athletes also can have heart disease and can collapse in the field.How can wearable digital devices help an athlete who has suspected arrhythmia?

Wearables & Heart Beats: Part 1

Smart gadgets are all around, in TVs, phones, cameras, cars, kitchens, and also on our skin! Bands, watches, rings, earbuds, and even shirts can monitor our bodies and give insights into our health and disease.The global Wearable Technology Market size was worth about 115.8 (USD billion) in 2021 and is predicted to grow to around 380.5 (USD billion) by 2028Wearables can measure the pulse and can even tell the heart rhythm. How can wearable technology’s ability to monitor rate and rhythm help in medicine? How accurate are they? Can physicians rely on them in the diagnosis and treatment of abnormal heart rhythms (arrhythmia)? The European heart rhythm association (EHRA) has recently released a practical guide on the use of digital devices to detect and manage arrhythmia and we are here to review it.I will not discuss medical devices such as Holter monitors or implantable devices that can deliver therapy such as pacemakers and life vests as they are well established, are prescribed and used by a physician, and fall outside the scope of this episode. We will give an overview of Devices that anyone can buy and use outside the hospitals; types and advantages of eachClinical application to evaluate palpitation

What is Precision Medicine?

How to tailor medicine for each and every individual person? Mixing clinical variables, genetic variants, and molecular profiles, all into Artificial Intelligence can lead to "Precision Medicine"...Interviewing Prof Maha Saber-Ayad, Professor of Pharmacology at Sharjah University on Pharmacogenomics and the quest for precision medicine.

The cathlab of Tomorrow. Hot from Paris Euro PCR 2022

Paris is not only the city of light, love, and culture but it is also the home of the biggest interventional cardiology meeting Paris Course on Revascularization PCR. Last week, the meeting was back in person after two years of COVID-imposed virtual attendance. Eight thousand attendees inside the “Palais de Congress”, tens of sessions, live cases, and industry stands. This version of Euro PCR celebrated 30 years of radial cath and 20 years of transcatheter aortic valve interventions (TAVI). I had the chance to attend, meet the experts, and present my cases. And I am here bringing to the cardio buzz audience, who couldn’t make it to the conference, the hot topics, and the latest breaking trials from Paris.7. Robots invade the cath lab6 Simulate before you operate5 Leaving nothing behind4 Fewer wires in, more data out3 How long will the valve live?2 Snuff boxers punched in the DISCO1 A Patch to Stop Bleeding

20: Is The Fault in our Genes?

Drawing a map of genes might help us predict who will get sick and when we will get sick of heart disease or cancer. And we have seen Angelina Jolie, the famous actress, going for a preventive mastectomy because she had a faulty gene for breast cancer. But Is it the inevitable destiny, or can we change it? Do genes decide who will have heart disease? Who is to be blamed for heart disease? The genes we inherit, or the environment where we grow and live?Can your good genes protect you from your unhealthy lifestyle? Can a good lifestyle buffer our faulty genes?Watch it 🎦 on YouTube Read 📖it on LinkedIn ReferencesCirculation. 2022;145:808–818. DOI: 10.1161/CIRCULATIONAHA.121.053730https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.053730

19: You Hit 40! Should You start Aspirin?

With all its health benefits, cheap, and with few side effects, Aspirin is in every house. Aspirin reduces mortality in acute myocardial infarction. It is intuitive to use it for prevention, not only for treatment. Some studies supported that practice.But in the 21st century, we realize that aspirin is a gastric irritant and can cause bleeding. We got better pain killers and more potent platelet inhibitors, and we started questioning aspirin's protective effect compared to other drugs. So what’s the truth about Aspirin? Should people above 40 with no heart or vascular disease take Aspirin to prevent heart attacks and strokes or not? LinkedIn articleYouTube VideoAspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement.” JAMA 327, no. 16 (April 26, 2022): 1577–84. https://doi.org/10.1001/jama.2022.4983https://www.cvriskcalculator.comhttps://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics

18: What’s new in the latest heart failure guidelines? Part 2

The new heart failure guidelines were released this month. Last week, we summarized staging, classification, and diagnostic workup points. You can find the contents of the first part as an audio in the last week of cardio buzz or on the Cardio Buzz Youtube channel.This week we will summarize the management of heart failure. Bring in your coffee because, again, this article will be rich in information and will need all our attention.Guidelines Full Text  👉 https://www.ahajournals.org/doi/10.1161/CIR.0000000000001063Cardio Buzz on YouTube 👉 https://www.youtube.com/c/DrHussienheart-talks/featuredCardio Buzz on LinkedIn 👉 https://www.linkedin.com/newsletters/weekly-cardiology-buzz-6923878426843971584/

17: What’s new in the latest heart failure guidelines? Part 1

The AHA, ACC, and HFSA have all joined efforts and just released the latest guidelines on heart failure. If you are a clinician, a nurse, or a healthcare provider involved in the care of patients with HF then these guidelines are for you. The full text comes in a big document of 138 pages. I will summarize the main points here over two episodes. The first episode will be on staging, classification, clinical assessment, and diagnostic workup. The second episode will describe the basics of treatment. So bring in your coffee because the episode will be rich in information and will need all our attention.https://www.ahajournals.org/doi/10.1161/CIR.0000000000001063

16: A Guardian in the Cathlab. Dr. Lorenz Azzalini on mechanical circulatory support devices

We all know that heart disease is the number 1 killer worldwide. And patients die either because of acute coronary syndromes (myocardial infarction) or because of left ventricular dysfunction (heart failure). And, as an interventionist, being trapped with both evils; severe coronary stenosis and left ventricular dysfunction is scary. The only solution then is usually revascularization but it also comes with risks of myocardial injury and impaired organ perfusion. There is already an entire system with bypass surgery that perfuses the organs while the heart is paralyzed, the bypass machine. Unfortunately, surgery is not always available, many patients refuse surgery, and others may be declined by the surgeons because of their high risk. Here, cath interventions are the only hope. In addition to the gadgets available to handle the coronary occlusions, there is a need for devices to support the circulation and blood pressure during cardiogenic shock or when the heart is stunned during complex coronary intervention. The last thing we want is to have a patient crashing on-table or shortly after.And to review these devices that support the heart and the circulation in complex PCI (I call them the guardian in the cath lab), I am glad to host today one of the International experts on complex coronary interventions and mechanical circulatory support. Dr. Lorenzo Azzalini. Dr. Azzalini is the Director of the Complex Coronary Interventions Program and associate professor of medicine at Virginia Commonwealth University, in Richmond, VA. Before joining VCU he was co-director of the chronic total occlusion program at San Raffaele Hospital in Milan, Italy. And San Rafaelle was one of the centers of excellence in Europe. Dr. Azzalini’s clinical and research expertise is represented by chronic total occlusion PCI, atherectomy, mechanical circulatory support, and acute kidney injury after PCI. He has over 170 international publications, more than 3700 citations, has received numerous international awards, is a member of the editorial board of the Canadian Journal of Cardiology, Eurointervention, Cardiovascular Revascularization Medicine, and Minerva Cardiology and Angiology, and is a guest reviewer for other twenty journals. And he is a wiz inside the cath lab. I had the chance to work with him several times in the cath lab and I would describe his skills as amazing.